MCF Advisors’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-41
Closed -$4.16K 1358
2025
Q4
$4.16K Hold
41
﹤0.01% 978
2025
Q3
$2.24K Hold
41
﹤0.01% 884
2025
Q2
$2.18K Hold
41
﹤0.01% 804
2025
Q1
$1.77K Hold
41
﹤0.01% 819
2024
Q4
$2.3K Hold
41
﹤0.01% 835
2024
Q3
$2.79K Hold
41
﹤0.01% 817
2024
Q2
$1.73K Hold
41
﹤0.01% 861
2024
Q1
$2.83K Sell
41
-170
-81% -$10.8K ﹤0.01% 781
2023
Q4
$15.6K Buy
211
+170
+415% +$11.1K ﹤0.01% 544
2023
Q3
$2.8K Hold
41
﹤0.01% 730
2023
Q2
$3.85K Hold
41
﹤0.01% 653
2023
Q1
$2.78K Hold
41
﹤0.01% 672
2022
Q4
$2.03K Hold
41
﹤0.01% 676
2022
Q3
$1K Hold
41
﹤0.01% 735
2022
Q2
$2K Hold
41
﹤0.01% 621
2022
Q1
$3K Buy
+41
New +$3K ﹤0.01% 596
2021
Q4
Sell
-41
Closed -$4K 247
2021
Q3
$4K Hold
41
﹤0.01% 534
2021
Q2
$5K Hold
41
﹤0.01% 495
2021
Q1
$5K Hold
41
﹤0.01% 459
2020
Q4
$5K Hold
41
﹤0.01% 416
2020
Q3
$4K Buy
+41
New +$3.54K ﹤0.01% 422

Other funds holding EXAS

MCF Advisors's EXAS Position: Q1 2026 in Review

MCF Advisors sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 41 shares — an estimated $4.16K sold.

MCF Advisors first reported a position in EXAS in Q3 2020 and held it in 21 quarters. The position peaked at $15.6K in Q4 2023. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • MCF Advisors reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • MCF Advisors sold 41 Exact Sciences shares in Q1 2026, an estimated $4.16K.
  • MCF Advisors first reported a position in Exact Sciences in Q3 2020 and held it in 21 quarters.
  • MCF Advisors's Exact Sciences position peaked at $15.6K in Q4 2023.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on MCF Advisors's 13F filing for Q1 2026, filed 11 May 2026.